Process Development of TRI-999, a Fatty-Acid-Modified HIV Fusion Inhibitory Peptide.

Autor: Huyi Zhang, Stephen E. Schneider, Brian L. Bray, Paul E. Friedrich, Nicolai A. Tvermoes, Catherine J. Mader, Sheila R. Whight, Toivo E. Niemi, Peter Silinski, Tony Picking, Marquitta Warren, Stephen A. Wring
Zdroj: Organic Process Research & Development; Dec2007, Vol. 12 Issue 1, p101-110, 10p
Databáze: Supplemental Index